Amy Truong is a clinician, strategist, and two-time founder who has spent her career bridging science, clinical care, and commercialization. She knows firsthand the friction points that founders encounter when moving from lab bench to clinical trial to health system adoption to market scale. Her experience spans clinical practice, public health, product-market fit, and strategic partnerships, giving her a unique vantage point across the full healthcare innovation spectrum.

As a founder, Amy has launched companies in both food and health (Mom’s Thai Food and Road to Wellness), raising capital, navigating regulations, and building teams. She understands the uphill climb of early-stage entrepreneurship, particularly the challenges of fundraising, system integration, and creating meaningful adoption pathways. This lived experience informs her empathy for founders who are building not just products, but movements for change.

Beyond her own ventures, Amy serves as a fractional leader and advisor for startups in biotech, medtech, and digital health, helping them design reimbursement models, scale operations, and navigate system integration. She has mentored through incubators and accelerators, graduated from the LA Biostart biotech incubator, and is now on her third startup. Across each role, she has focused on bringing innovative technologies into complex systems in ways that meet the needs of patients, providers, and payors alike.

Currently pursuing her MBA at UCLA Anderson and serving as an Investment Fellow with the Material Change Institute, Amy is formalizing her role as an emerging investor. Her focus is on investing mindfully and intentionally in mission-driven founders — particularly those who are building companies that improve health, create access, and generate economic mobility. She is passionate about backing founders who are creating “goodness” in the world, while equipping them with the mentorship, regulatory navigation, integration pathways, and partnerships they need to succeed.

Amy believes the next generation of healthcare innovation will be built not only by capital, but by ecosystems that support founders in tackling the hard problems of scale, equity, and adoption. With her background spanning clinical care, public health, system transformation, and venture building, she is committed to being part of that solution — both as an operator and as an investor.